BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9698370)

  • 1. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
    Duranton J; Adam C; Bieth JG
    Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
    Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG
    J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
    Boudier C; Cadène M; Bieth JG
    Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P; Chignard M
    J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor.
    Duranton J; Boudier C; Belorgey D; Mellet P; Bieth JG
    J Biol Chem; 2000 Feb; 275(6):3787-92. PubMed ID: 10660528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo.
    Duranton J; Bieth JG
    Am J Respir Cell Mol Biol; 2003 Jul; 29(1):57-61. PubMed ID: 12600819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P; Ferrer-Lopez P; Chignard M
    Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.
    Patston PA
    Inflammation; 1995 Feb; 19(1):75-81. PubMed ID: 7705888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis.
    Stockley RA; Shaw J; Afford SC; Morrison HM; Burnett D
    Am J Respir Cell Mol Biol; 1990 Feb; 2(2):163-70. PubMed ID: 2306372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).
    Mast AE; Enghild JJ; Nagase H; Suzuki K; Pizzo SV; Salvesen G
    J Biol Chem; 1991 Aug; 266(24):15810-6. PubMed ID: 1651920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P; Chignard M
    J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
    Owen CA; Campbell EJ
    J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cathepsin G by 2-amino-3,1-benzoxazin-4-ones: kinetic investigations and docking studies.
    Gütschow M; Kuerschner L; Pietsch M; Ambrozak A; Neumann U; Günther R; Hofmann HJ
    Arch Biochem Biophys; 2002 Jun; 402(2):180-91. PubMed ID: 12051662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
    Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
    Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
    Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human chymotrypsin-like proteases by alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
    Hayem A; Marko D; Laine A; Davril M
    Adv Exp Med Biol; 1988; 240():97-9. PubMed ID: 3266711
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
    Pizzo SV; Mast AE; Feldman SR; Salvesen G
    Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.